Richard Seto, MD
Rheumatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Seto’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A156895 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$84,510
Medicare paid this office $84,510 for 268 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 156 | $36,173 | $112 |
| New patient visit (45+ min) | 85 | $12,465 | $147 |
| Long return visit (40+ min) | 49 | $8,921 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,650 | $152 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 119 | $3,259 | $15 |
See all 7 services
| Return visit (30+ min) | 156 | $36,173 | $112 |
| New patient visit (45+ min) | 85 | $12,465 | $147 |
| Long return visit (40+ min) | 49 | $8,921 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,650 | $152 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 119 | $3,259 | $15 |
| New patient visit (60+ min) | 16 | $3,090 | $193 |
| Short return visit (20+ min) | 11 | $1,063 | $82 |
Who their Medicare patients are
268 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 23% · Women 63% · Also on Medicaid 11% · Health risk score 1.19. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 67% · Chronic kidney disease 33% · Coronary heart disease 28% · Diabetes 25% · Cancer 18% · Atrial fibrillation 17% · Depression 16% · Heart failure 13% · COPD 11% · Stroke 7% · Dementia 6%.
The office billed $287,428, Medicare allowed $113,336 and paid $84,510; for 2,164 services of 19 kinds; $13,652 of it was for drugs given in the office and $70,858 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 268 | 2,164 | 76 | 1.19 | $287,428 | $84,510 |
| 2023 | 202 | 910 | 77 | 1.11 | $184,982 | $54,561 |
| 2022 | 83 | 174 | 77 | 1.13 | $52,306 | $16,856 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 115 | $26,135 | $106 |
| New patient visit (45+ min) | 80 | $12,052 | $151 |
| Long return visit (40+ min) | 26 | $4,259 | $158 |
| New patient visit (60+ min) | 14 | $2,898 | $207 |
2022: 4 services
| Return visit (30+ min) | 48 | $7,189 | $118 |
| New patient visit (45+ min) | 25 | $3,933 | $157 |
| New patient visit (60+ min) | 12 | $2,490 | $207 |
| Long return visit (40+ min) | 12 | $2,054 | $158 |
Drugs they prescribed that Part D paid
$606,885
Pharmacies billed $606,885 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 696) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
595 generic and 101 brand-name prescriptions · $606,885 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 30 | $207,427 | $6,914 |
| Enbrel Sureclick | 25 | $185,865 | $7,435 |
| Taltz | 12 | $81,333 | $6,778 |
| Methotrexate | 79 | $2,603 | $33 |
| Colchicine | 40 | $2,416 | $60 |
See all 13 drugs
| Humira(Cf) | 30 | $207,427 | $6,914 |
| Enbrel Sureclick | 25 | $185,865 | $7,435 |
| Taltz | 12 | $81,333 | $6,778 |
| Methotrexate | 79 | $2,603 | $33 |
| Colchicine | 40 | $2,416 | $60 |
| Mycophenolate Mofetil | 19 | $1,894 | $100 |
| Hydroxychloroquine Sulfate | 31 | $1,552 | $50 |
| Leflunomide | 27 | $1,417 | $52 |
| Prednisone | 156 | $1,340 | $9 |
| Allopurinol | 143 | $1,316 | $9 |
| Sulfasalazine | 11 | $132 | $12 |
| Alendronate | 11 | $91 | $8 |
| Folic Acid | 11 | $48 | $4 |
Year by year
| 2024 | 696 | 145 | 0% (0) | 15% | $606,885 |
| 2023 | 528 | 112 | 0% (0) | 11% | $413,947 |
| 2022 | 197 | 57 | 0% (0) | None | $228,915 |
| 2021 | 73 | 15 | None | 47% | $185,524 |
| 2020 | 163 | 30 | None | None | $74,749 |
| 2019 | 223 | 52 | 0% (0) | None | $128,412 |
| 2018 | 77 | 21 | 0% (0) | None | $8,711 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Enbrel Sureclick | 26 | $187,504 | $7,212 |
| Humira(Cf) | 12 | $86,674 | $7,223 |
| Methotrexate | 45 | $2,834 | $63 |
| Leflunomide | 18 | $1,995 | $111 |
| Colchicine | 40 | $1,995 | $50 |
| Hydroxychloroquine Sulfate | 25 | $1,871 | $75 |
| Prednisone | 124 | $1,628 | $13 |
| Allopurinol | 105 | $1,289 | $12 |
| Duloxetine | 16 | $684 | $43 |
| Alendronate | 32 | $328 | $10 |
| Pantoprazole | 11 | $190 | $17 |
| Folic Acid | 17 | $49 | $3 |
2022: 6 drugs
| Enbrel Sureclick | None | 18 | $124,076 | $6,893 |
| Gamunex-C | Immune globulin | 21 | $53,484 | $2,547 |
| Hydroxychloroquine Sulfate | None | 16 | $1,545 | $97 |
| Methotrexate | None | 17 | $914 | $54 |
| Prednisone | None | 37 | $714 | $19 |
| Alendronate | None | 11 | $86 | $8 |
2020: 3 drugs
| Methotrexate | 14 | $630 | $45 |
| Atorvastatin | 16 | $199 | $12 |
| Amlodipine Besylate | 11 | $76 | $7 |
2019: 4 drugs
| Humira | 16 | $83,859 | $5,241 |
| Atorvastatin | 21 | $465 | $22 |
| Methotrexate | 14 | $450 | $32 |
| Metoprolol | 11 | $64 | $6 |
Money from drug and device companies
$161 in 2025
| 2025 | 2 | 3 | None | $161 |
| 2024 | 1 | 5 | None | $89 |
| 2023 | 3 | 5 | None | $282 |
| 2022 | 2 | 2 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $119 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $41 | 2 payments
|
See all 3 published payments
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-06-06 | Cosentyx | $27 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $119 |
See earlier years (2024, 2023, 2022)
2024: $89
| Novartis Pharmaceuticals | Cosentyx | $89 | 5 payments
|
2023: $282
| AstraZeneca Pharmaceuticals LP | Saphnelo | $125 | 1 payment
|
| AbbVie | Rinvoq | $86 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $71 | 3 payments
|
2022: $31
| Abbvie | Rinvoq | $17 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $14 | 1 payment
|
Professional record
- NPI
- 1720529167
- Licence
- CA A156895California A156895: Current · expires 2028-07-31
- Trained
- Rush Medical College of Rush University, 2017
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-03-18
- NPI last updated
- 2022-08-11
- NPI record certified
- 2022-08-11
This is when the NPI record was last certified, not a medical board exam.